SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (18116)1/25/1999 9:41:00 AM
From: Mkilloran  Respond to of 23519
 
vlad,,,here's the news on Viagra approval in Japan and the potential size of the market.

Vivus needs to move on getting a partner for Japan and go get 10% of this market for MUSE in 1999.

#reply-7464624



To: VLAD who wrote (18116)1/25/1999 10:14:00 AM
From: BigKNY3  Respond to of 23519
 
V-Man <<Kahuna, What's the relevance to Vivus?>>

No relevance at all. Sorry for the misplaced post.

BigKNY3



To: VLAD who wrote (18116)1/25/1999 1:36:00 PM
From: RT  Read Replies (1) | Respond to of 23519
 
VLAD,

I have a serious question to ask. Does the size of the penis have anything to do with the dosage required to gain an erection? If there is a correlation between size and dosage maybe Vivus could dump all those 125mg units on the Japanese.
JUST A FLEETING THOUGHT.

RT



To: VLAD who wrote (18116)1/25/1999 5:56:00 PM
From: Mkilloran  Respond to of 23519
 
Vlad...Doctors in the UK have to follow the NHS rules or pay out of their own pocket....

news.bbc.co.uk


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News